What Has Been the Growth of the Sequencing Reagents Market So Far?
The sequencing reagents market has seen considerable growth due to a variety of factors.
• The sequencing reagents market has grown rapidly, from $10.45 billion in 2024 to $12.21 billion in 2025, at a CAGR of 16.9%.
The growth can be attributed to the adoption of sequencing in drug discovery and development, government initiatives promoting genomics research, the growing application of sequencing in clinical diagnostics, the rise in genetic disorders, and the rise of precision medicine.
What Is the Forecasted Market Size and Growth Rate for The Sequencing Reagents Market Size In The Coming Years?
The sequencing reagents market is expected to maintain its strong growth trajectory in upcoming years.
• The sequencing reagents market is projected to reach $22.5 billion by 2029, growing at a CAGR of 16.5%.
The growth is driven by cancer genomics research, bioinformatics tools growth, genomics research investments, personalized medicine demand, and sequencing applications in agriculture and livestock. Trends include portable sequencing platforms, sequencing integration with other technologies, novel reagents development, and increased R&D investment.
What Factors Are Driving Growth In The Sequencing Reagents Market?
Personalized medicine's growing demand and evolution are predicted to fuel the expansion of the sequencing reagents market. This cutting-edge approach to healthcare, also referred to as precision medicine, customizes medical decisions and intervention strategies to each patient's specific traits. The surge in personalized medicine's popularity is powered by advancements in genomics and molecular diagnostics, which permit treatment customization based on individual genetic profiles and disease attributes. Sequencing reagents contribute significantly to personalized medicine by facilitating accurate analysis of personal genetic data for customized diagnostic and treatment interventions. The Personalized Medicine Coalition (PMC), a non-profit organization based in the U.S., reported in February 2024 that personalized medicines accounted for more than a third of the new U.S. Food and Drug Administration (FDA) drug approvals for the fourth consecutive year in 2023. Moreover, in 2023, the FDA endorsed 16 new personalized treatments for patients with rare diseases, an increase from six in 2022. Therefore, the growing demand and evolution of personalized medicine are expected to spur the growth of the sequencing reagents market.
What Are The Main Segments Of The Global Sequencing Reagents Market?
The sequencing reagents market covered in this report is segmented –
1) By Type: Library Kits, Template Kits, Control Kits, Sequencing Kits, Other Types
2) By Technology: Sanger Sequencing, Next Generation Sequencing, Third Generation Sequencing
3) By Application: Oncology, Reproductive Health, Clinical Investigation, Agrigenomics And Forensics, Other Applications
4) By Industry Verticals: Research Institutes, Hospitals and Clinics, Pharmaceutical And Biotechnology Companies, Other Industry Verticals
Subsegments:
1) By Library Kits: Dna Library Kits, Rna Library Kits, Whole Genome Library Kits, Targeted Sequencing Library Kits, Amplicon Library Kits
2) By Template Kits: Dna Template Kits, Rna Template Kits, Cdna Template Kits, Single-Cell Rna Template Kits
3) By Control Kits: Positive Control Kits, Negative Control Kits, Internal Control Kits, Quality Control Kits
4) By Sequencing Kits: Next-Generation Sequencing (Ngs) Kits, Whole Genome Sequencing Kits, Targeted Sequencing Kits, Exome Sequencing Kits, Rna Sequencing Kits
5) By Other Types: Pcr Reagents And Kits, Cloning Kits, Multiplexing Kits, Sanger Sequencing Reagents
Pre-Book The Sequencing Reagents Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Sequencing Reagents Market?
Leading companies in the sequencing reagents market are innovating new technology, such as Illumina Complete Long Read technology, in an effort to gain a competitive advantage. Illumina's Complete Long-Read technology merges the precision and speed of short-read sequencing with the extensive coverage and ability to bridge complex genomic regions characteristic of long-read sequencing. For example, in March 2023, Illumina Inc., a biotechnology firm based in the US, introduced the Illumina Complete Long Read Prep, Human. This sophisticated, long-read, human whole-genome sequencing (WGS) assay works in sync with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. Illumina's Complete Long Read Prep for Humans is a comprehensive procedure that supports long-read sequencing of the human genome on Illumina platforms, covering everything from sample processing to library construction and sequencing. This allows researchers to produce long sequencing reads for in-depth genomic analysis, such as pinpointing structural variations and complicated genomic regions.
Who Are the Key Players In The Sequencing Reagents Market?
Major companies operating in the sequencing reagents market are:
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• BGI Group
• Beckman Coulter Inc.
• Hamilton Company
• GenScript Biotech Corporation
• Promega Corporation
• Integrated DNA Technologies (IDT)
• BioLegend
• Twist Bioscience
• Diagenode
• Covaris Inc.
• Oxford Nanopore Technologies plc
• Biotage
• Takara Bio Inc.
• New England Biolabs (NEB)
• Pacific Biosciences of California Inc.
• Zymo Research
• Lucigen Corporation
• Norgen Biotek Corp.
• Lexogen GmbH
• Daicel Arbor Biosciences
• Swift Biosciences Inc.
What Is The Most Dominant Region In The Sequencing Reagents Market?
North America was the largest region in the sequencing reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sequencing reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
